The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...
Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...
ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio Scientific (Euronext ...
SEOUL, South Korea, Dec. 25, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for ...
Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic. ABL, a Korean biotech that is partnered with companies ...
Eli Lilly has signed an agreement with ABL Biotech for access to the South Korean biotech's Grabody platform to develop bispecific antibodies that is worth up to $2.6B. Deal terms call for ABL Bio to ...
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore ...